These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 6736500)
41. Toward a biochemical classification of depressive disorders, V: Heterogeneity of unipolar depressions. Schatzberg AF; Orsulak PJ; Rosenbaum AH; Maruta T; Kruger ER; Cole JO; Schildkraut JJ Am J Psychiatry; 1982 Apr; 139(4):471-5. PubMed ID: 7065292 [TBL] [Abstract][Full Text] [Related]
42. Urinary MHPG and ward behavior in unmedicated psychiatric patients. Mueser KT; Rosen AJ; Dysken MW; Javaid JI Psychiatry Res; 1983 Dec; 10(4):275-83. PubMed ID: 6583716 [TBL] [Abstract][Full Text] [Related]
43. Conversion of MHPG to vanillylmandelic acid. Implications for the importance of urinary MHPG. Blombery PA; Kopin IJ; Gordon EK; Markey SP; Ebert MH Arch Gen Psychiatry; 1980 Oct; 37(10):1095-8. PubMed ID: 7425794 [TBL] [Abstract][Full Text] [Related]
44. Monoamine metabolism during chronic benzodiazepine treatment and withdrawal. Petursson H; Bond PA; Smith B; Lader MH Biol Psychiatry; 1983 Feb; 18(2):207-13. PubMed ID: 6187380 [TBL] [Abstract][Full Text] [Related]
45. [Different urinary excretion of 3-methoxy-4-hydroxyphenyl-glycol and response to tricyclic antidepressive drugs]. Beckmann H; Jones C; Goodwin FK Arzneimittelforschung; 1974 Jul; 24(7):1010-2. PubMed ID: 4408047 [No Abstract] [Full Text] [Related]
46. Effects of d-amphetamine on urinary metabolites of dopamine and norepinephrine in hyperactive boys. Shekim WO; Javaid J; Dekirmenjian H; Chapel JL; Davis JM Am J Psychiatry; 1982 Apr; 139(4):485-8. PubMed ID: 7065295 [TBL] [Abstract][Full Text] [Related]
47. A pharmacologic study of the stiff-man syndrome. Correlation of clinical symptoms with urinary 3-methoxy-4-hydroxy-phenyl glycol excretion. Schmidt RT; Stahl SM; Spehlmann R Neurology; 1975 Jul; 25(7):622-6. PubMed ID: 1171392 [TBL] [Abstract][Full Text] [Related]
48. CSF and urine biogenic amine metabolites in Rett syndrome. Lekman A; Witt-Engerström I; Holmberg B; Percy A; Svennerholm L; Hagberg B Clin Genet; 1990 Mar; 37(3):173-8. PubMed ID: 1691058 [TBL] [Abstract][Full Text] [Related]
49. Urinary MHPG and HVA excretion in boys with attention deficit disorder and hyperactivity treated with d-amphetamine. Shekim WO; Javaid J; Davis JM; Bylund DB Biol Psychiatry; 1983 Jun; 18(6):707-14. PubMed ID: 6871304 [TBL] [Abstract][Full Text] [Related]
50. Origin and distribution of 3-methoxy-4-hydroxyphenylglycol in body fluids. DeMet EM; Halaris AE Biochem Pharmacol; 1979 Oct; 28(20):3043-50. PubMed ID: 391236 [No Abstract] [Full Text] [Related]
51. [Urinary excretion of MHPG in endogenous depression. Clinico-therapeutic index]. Roccatagliata G; Maini A; Bino G Minerva Psichiatr; 1981; 22(2):75-8. PubMed ID: 7266322 [No Abstract] [Full Text] [Related]
52. Toward a biochemical classification of depressive disorders. II. Application of multivariate discriminant function analysis to data on urinary catecholamines and metabolites. Schildkraut JJ; Orsulak PJ; LaBrie RA; Schatzberg AF; Gudeman JE; Cole JO; Rohde WA Arch Gen Psychiatry; 1978 Dec; 35(12):1436-9. PubMed ID: 727879 [TBL] [Abstract][Full Text] [Related]
53. Estimation of the contribution of peripheral and central noradrenergic neurones to urinary 3-methoxy-4-hydroxyphenylglycol in the rat. Karoum F; Wyatt R; Costa E Neuropharmacology; 1974 Mar; 13(3):165-76. PubMed ID: 4840872 [No Abstract] [Full Text] [Related]
54. Determination of 4-O-methylated catecholamine metabolites in urine by mass fragmentography. Muskiet FA; Fremouw-Ottevangers DC; Nagel GT; Wolthers BG Clin Chem; 1979 Oct; 25(10):1708-13. PubMed ID: 476919 [TBL] [Abstract][Full Text] [Related]
55. Low level of urinary 5-hydroxyindole acetic acid (5 HIAA) in obese children having concomitantly high 3-methoxy-4-hydroxyphenyl glycol (MHPG) excretion. Popa M; Stefănescu AM; Dumitriu L Endocrinologie; 1989; 27(1):29-34. PubMed ID: 2474191 [TBL] [Abstract][Full Text] [Related]
56. 4-methoxy-3-hydroxyphenylglycol as an internal standard for the determination of 3-methoxy-4-hydroxyphenyglycol in urine: results obtained in depressed patients and healthy controls. Gaertner HJ; Wiatr G; Kuss HJ J Clin Chem Clin Biochem; 1980 Sep; 18(9):579-83. PubMed ID: 7441185 [TBL] [Abstract][Full Text] [Related]
57. Modification of assays for the routine analysis of 3-methoxy-4-hydroxyphenylglycol in urine by electron-capture gas chromatography. Lombrozo L; Anderson TJ; Kanaske K; Hollister LE J Chromatogr; 1980 Jan; 181(1):1-10. PubMed ID: 7364900 [TBL] [Abstract][Full Text] [Related]
58. MHPG excretion in depressive disorders: relation to clinical subtypes and desynchronized sleep. Schildkraut JJ; Keeler BA; Papousek M; Hartmann E Science; 1973 Aug; 181(4101):762-4. PubMed ID: 4353428 [TBL] [Abstract][Full Text] [Related]
59. Determination of urinary 3-methoxy-4-hydroxyphenylglycol by liquid chromatography with electrochemical detection. Koch DD; Polzin G J Chromatogr; 1984 Dec; 317():327-31. PubMed ID: 6530439 [TBL] [Abstract][Full Text] [Related]
60. Relative activity of metabolic pathways for norepinephrine in endogenous depression. Roy A; Linnoila M; Karoum F; Pickar D Acta Psychiatr Scand; 1986 Jun; 73(6):624-8. PubMed ID: 3751666 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]